|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The value of anti- Mullerian hormone measurement in the long GnRH agonist protocol : association with ovarian response and gonadotrophin-dose adjustments显示文摘 | Anckaert E Smitz J Schiettecatte J | 2012 | Hum Reprod2012，27，： | 1 |
| 2 | Unaltered imprinting establishment of key imprinted genes in mouse oocytes after in vitro follicle culture under variable follicle-stimulating hormone exposure显示文摘 | Anckaert E Adriaenssens T Romero S | 2009 | Int J Dev Biol2009，53，4： | 1 |
| 3 | Software protection through dynamic code mutation显示文摘 | Madou M Anckaert B Moseley P | | 0，，： | 1 |
| 4 | Culture of oocytes and risk of imprinting defects 显示文摘 | Anckaert E De Rycke M Smitz J | 2013 | Hum Reprod Update2013，19，1： | 1 |
| 5 | The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol:association with ovarian response and gonadotrophin-dose adjustments显示文摘 | Anckaert E Smitz J Schiettecatte J | 2012 | Hum Reprod2012，27，6： | 1 |
| 6 | Circulating anti-prolactin auto-antibodies must be considered in the differential diagnosis of hyperprolactinaemia in adolescents 显示文摘 | VANBESIEN J SCHIETIECATTE J ANCKAERT E | 2002 | Eur J Pediatr2002，161，7： | 1 |
| 7 | Multicenter evalustion of the first automated Elecsys s Flt-1 and Pl GF assays in normal pregnancies and preeclampsis显示文摘 | Schiettecatte J Russcher H Anckaert E | 2010 | Clin Biochem2010，43，9： | 1 |
| 8 | Multi-center evaluation of the first automated Elecsys sFlt- 1 and P1GF assays in normal pregnancies and preeclampsia 显示文摘 | Schicttecatte J Russcher H Anckaert E | 2010 | Clin Biochem2010，43，9： | 1 |
| 9 | Muhicenter evalua- tion of the first automated Elecsys sFh-1 and P1GF assays innormal pregnancies and preeclampsia 显示文摘 | Schiettecatte J Russcher H Anckaert E | 2010 | Clin Biochem2010，43，9： | 1 |
| 10 | Unaltered imprinting establishment of key imprinted genes in mouse oocytes after in vitro follicle culture under variable follicle -stimulating hormone exposure显示文摘 | Anckaert E Adriaenssens T Romero S | 2009 | Int J Dev Biol2009，53，4： | 1 |
| 11 | Run-time randomization to mitigate tampering显示文摘 | Anckaert B Jakubowski M Venkatesan R De Bosschere K | 2007 | Advances in Information and Computer Security2007，4752，： | 1 |
| 12 | Clinical validation of a fully automated 17beta-estradiol and progesterone assay (VIDAS) for use in monitoring assisted reproduction treatment显示文摘 | Anckaert E Mees M Schiettecatte J | 2002 | Clin Chem Lab Med2002，40，8： | 1 |
| 13 | Multicenter evaluation of the first automated Elecsys sFh-1 and P1GF assays in normal pregnancies and preeelampsia 显示文摘 | Schiettecatte J Russcherb H Anckaert E | 2010 | Clinl Biochem2010，43，9： | 1 |
| 14 | Culture of oocytes and risk of imprinting defects 显示文摘 | Anckaert E De Rycke M Smitz J | 2013 | Hum Reprod Update2013，19，1： | 1 |
| 15 | 在体外受精周期中应用自动化免疫测定法测定血清雌二醇水平假性升高,罕见地导致不必要的周期取消显示文摘Objective: To report a case of a patient in whom serum E2, as measured by an automated E2 assay, remained elevated at levels corresponding to the periovulatory phase(>380 pg/mL), despite 3 weeks of treatment by a GnRH agonist(GnRH-a). Design: Case report. Setting: Tertiary-care academic center. Patient(s): A 39-year-old patient accepted for IVF treatment. In view of controlled ovarian hyperstimulation, down-regulation by a GnRH-a was monitored by serum E2 measurement. Intervention( s): Obvious causes for high serum E2 levels(pregnancy, E2-produ- cing ovarian cysts, and noncompliance of the patient)-were excluded. The IVF cycle was canceled. Main Outcome Measure(s): Serum samples were analyzed retrospectively by radioimmunoassay(RIA), and ether extraction of the samples was performed before measurement by the automated E2 assay. Result(s): Radioimmunoassay revealed adequately suppressed serum E2 levels under GnRH-a treatment(< 15 pg/mL). Ether extraction revealed an interfering component that was soluble in the aqueous phase. Conclusion(s): If a patient on a long controlled ovarian hyperstimulation IVF protocol still has high serum E2 levels after 2 to 3 weeks of down-regulation, and obvious reasons for this(pregnancy, E2 producing ovarian cysts, noncompliance of the patient) are excluded, E2 immunoassay interference should be excluded to avoid unnecessary cancellation of the IVF cycle. | Anckaert E. Platteau P. Schiettecatte J. 党慧敏 | 2006 | 世界核心医学期刊文摘(妇产科学分册)2006，0，10： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员